AzTrials
AzTrials

Embryo DevelopmentNCT01767805

Impact of Culture Conditions on the Embryo Quality

A study testing Standard incubator, Mini incubator and 5% oxygen in people with Embryo Development, run by University Hospital, Gasthuisberg at 2 sites in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare different culture conditions. The effect of the type of incubator (standard versus mini-incubator) and the effect of the oxygen concentration (5% versus 20%) will be evaluated on the embryo quality Read more about this study

Who is it for?
Ages 1 day to 3 daysHealthy volunteers can take part
Conditions the study is for
Embryo Development
What is being tested?
Standard incubator, Mini incubator and 5% oxygen
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
790 participants
Where
2 sitesBelgium
Study dates
Jun 2009to Sep 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 3 days
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • embryos of patients younger than 36 years old

Who cannot join

  • embryos of patients older than 36 years old

Trial locations and contacts

2 sites in 1 country.

Belgium2 sites
  • University Hospital Leuven, Catholic University Leuven

    Leuven, Leuven, 3000

  • University Hospital Leuven, Catholic University Leuven

    Leuven

Other trials in Belgium

About this study

The purpose of this study is to compare different culture conditions. The effect of the type of incubator (standard versus mini-incubator) and the effect of the oxygen concentration (5% versus 20%) will be evaluated on the embryo quality

Being tested
Standard incubator, Mini incubator, 5% oxygen, 20% oxygen

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard incubatorProcedure or surgery

  • Mini incubatorProcedure or surgery

  • 5% oxygenProcedure or surgery

  • 20% oxygenProcedure or surgery

Study groups in NCT01767805
Study groupRoleWhat they receive
Type of incubatorOtherEmbryos are cultured in a standard incubator or a mini-incubator
Receives: Procedure: Standard incubator; Procedure: Mini incubator
Oxygen concentrationOtherEmbryos are cultured in an incubator with a gas mixture with 20% oxygen or with 5% oxygen
Receives: Procedure: 5% oxygen; Procedure: 20% oxygen

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. embryo quality

    Measured: day 1- day 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2013 (estimated)
  2. Study startJun 2009
  3. Primary completionSep 2010
  4. Study completionSep 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
790 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01767805
Sponsor's protocol ID
ML4563
Status last verified
Jan 2013
First submitted
8 Jan 2013
Last updated
14 Jan 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Standard incubator, Mini incubator and 5% oxygen in people with Embryo Development, run by University Hospital, Gasthuisberg at 2 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

embryo quality (time frame: day 1- day 3). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in